REGN
Regeneron Pharmaceuticals Inc.
$595.68
+$3.69(+0.62%)
75
Overall
80
Value
70
Tech
--
Quality
Market Cap
$62.74B
Volume
904.73K
52W Range
$476.49 - $1,154.56
Target Price
$729.50
Key Metrics Overview
| Market Cap | $62.74B | P/E Ratio | 19.31 |
| 52W High | $1,154.56 | 52W Low | $476.49 |
| Div Yield | 352.0% | Payout Ratio | 18.3% |
| EPS Growth 3Y | -18.8% | 52W Position | 17.6% |
| Overall Score | 75 | Value Score | 80 |
| Quality Score | -- | Technical Score | 70 |
Growth Analysis
| EPS Current Est | $30.85 | EPS Next Est | $31.53 |
| EPS Growth Est | +2.2% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | REGN | $595.68 | +0.6% | 904.73K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Regeneron Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW